AMENDMENT NO. 1 TO LICENSE AGREEMENTNektar Therapeutics • November 7th, 2013 • Pharmaceutical preparations
This Amendment No. 1 (the “Amendment”) to that certain License Agreement dated September 20, 2009 (the “Agreement”) is made and entered into effective as of August 8, 2013 (the “Effective Date of the Amendment”), by and between AstraZeneca AB, a Swedish corporation, with offices at S-151 85 Södertälje, Sweden (“AstraZeneca”) and Nektar Therapeutics, a Delaware corporation, with offices at 455 Mission Bay Boulevard South, San Francisco, California 94158 USA (“Nektar”).
